自動化和封閉式細胞治療處理系統市場規模、佔有率和成長分析：按系統類型、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球自動化密封細胞治療處理系統市值為 15.2 億美元，預計到 2025 年將成長至 17.5 億美元，到 2033 年將成長至 55.2 億美元，在預測期（2026-2033 年）內複合年成長率為 15.32%。

受CAR-T療法和幹細胞療法等先進治療方法擴充性且安全生產需求的推動，全球自動化封閉式細胞治療處理系統市場正在快速擴張。這些平台將細胞分離和配製等多種流程整合於密封環境中，從而降低污染風險和操作人員差異。這對於確保患者安全和獲得一致的臨床療效至關重要。隨著細胞療法產品臨床研發管線的擴展，利用自動化技術最大限度地減少差異和監管核准不確定性的標準化平台的投資也不斷增加。人工智慧的整合實現了預測分析、機器視覺和編配軟體，從而提高了營運效率。這項技術進步有助於從先導計畫過渡到全面生產，從而加速產能提升，緩解物流挑戰，並擴大患者群體。

全球自動化密封細胞治療處理系統市場的成長要素

全球自動化封閉式細胞治療處理系統市場的主要促進因素之一是再生醫學領域對先進治療方法和個人化治療方案日益成長的需求。除了慢性病盛行率不斷上升之外，細胞治療技術的進步也推動了對高效可靠處理系統的需求。對於希望擴大生產規模的製造商而言，自動化至關重要，因為它能夠提高可重複性、最大限度地降低污染風險並提升整體生產效率。此外，監管機構對創新醫療技術的支持以及研發投入的增加預計將進一步促進該領域的市場成長。

全球自動化密封細胞治療處理系統市場的限制因素

全球自動化封閉式細胞治療處理系統市場的主要限制因素是先進系統技術的實施和維護高成本。這些系統需要對專用設備、培訓和持續支援進行大量投資，這對於小規模的醫療機構和研究機構可能構成障礙。此外，監管障礙以及對自動化流程標準化的擔憂可能會進一步增加實施難度，並限制市場成長。各機構在權衡收益與財務影響時，整合的複雜性和成本可能會阻礙系統的廣泛應用，並阻礙細胞治療技術的創新和普及。

自動化封閉式細胞治療處理系統的全球市場趨勢

全球自動化封閉式細胞治療處理系統市場正呈現出顯著的標準化趨勢，從而提升了擴充性和營運效率。業界就協議、介面和品質指標達成共識，最大限度地減少了工作流程中的不一致性，並促進了不同平台間的模組化互通性。供應商和臨床專家在通用資料格式和檢驗框架方面的合作，簡化了技術轉移流程，從而建立了一個值得信賴的供應商生態系統。因此，營運摩擦得以減少，監管討論可以集中於實現一致的治療結果，供應商也能更有信心地擴大產能，並以可預測且高效的方式複​​製成功的治療方法。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球自動化密封細胞治療處理系統市場規模：依系統類型分類

• 細胞分離系統
• 細胞增殖系統
• 細胞洗滌和製備
• 冷凍保存系統

全球自動化密封細胞治療處理系統市場規模：依技術分類

• 自動化平台
• 閉合迴路系統

全球自動化密封細胞治療處理系統市場規模：按應用領域分類

• CAR-T細胞製造
• NK細胞療法
• 幹細胞療法

全球自動化密封細胞治療處理系統市場規模：以最終用戶分類

• 細胞療法生產商
• 學術研究機構
• CDMO

全球自動化密封細胞治療處理系統市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Miltenyi Biotec（CliniMACS）
• Cytiva（Danaher）-Sepax
• Thermo Fisher Scientific
• Terumo BCT
• Fresenius Kabi
• BioSpherix Ltd.
• Wilson Wolf Manufacturing
• Ori Biotech
• Octane Biotech（Cytiva）
• Multiply Labs
• MaxCyte Inc.
• Lonza Group（Cocoon Platform）
• ThermoGenesis Holdings
• Global Blood Therapeutics
• Cellero（Novatek）
• Charles River Laboratories
• PCT（Hitachi）
• BioAtla
• Cellipont Bioservices
• AMPIO Pharmaceuticals

結論與建議

Global Automated And Closed Cell Therapy Processing Systems Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.75 Billion in 2025 to USD 5.52 Billion by 2033, growing at a CAGR of 15.32% during the forecast period (2026-2033).

The global market for automated and closed cell therapy processing systems is increasingly driven by the demand for scalable, safe manufacturing of advanced therapies, such as CAR T and stem cell treatments. These platforms integrate various processes, including cell isolation and formulation, within a contained environment to mitigate contamination risks and operator variability, which are critical for ensuring patient safety and consistent clinical outcomes. As the clinical pipeline for cell-based products expands, there is growing investment in standardized platforms that leverage automation to minimize variability and regulatory approval uncertainties. The integration of AI enhances operational efficiency by enabling predictive analytics, machine vision, and orchestration software. This technological progress supports the transition from pilot projects to full-scale production, thereby increasing capacity, reducing logistics challenges, and accelerating patient access.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated And Closed Cell Therapy Processing Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated And Closed Cell Therapy Processing Systems Market Segments Analysis

Global automated and closed cell therapy processing systems market is segmented by system type, technology, application, end-user and region. Based on system type, the market is segmented into Cell Isolation Systems, Cell Expansion Systems, Cell Washing & Formulation and Cryopreservation Systems. Based on technology, the market is segmented into Automated Platforms and Closed-Loop Systems. Based on application, the market is segmented into CAR-T Cell Manufacturing, NK Cell Therapy and Stem Cell Therapy. Based on end-user, the market is segmented into Cell Therapy Manufacturers, Academic Research Centers and CDMOs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Automated And Closed Cell Therapy Processing Systems Market

One of the key market drivers for the Global Automated and Closed Cell Therapy Processing Systems Market is the increasing demand for advanced therapies in regenerative medicine and personalized treatment options. The growing prevalence of chronic diseases, along with advancements in cell therapy techniques, has accelerated the need for efficient and reliable processing systems. Automation enhances reproducibility, minimizes contamination risks, and improves overall productivity, making it essential for manufacturers looking to scale their operations. Furthermore, regulatory support for innovative medical technologies and rising investments in research and development are expected to further bolster market growth in this sector.

Restraints in the Global Automated And Closed Cell Therapy Processing Systems Market

A key market restraint for the Global Automated and Closed Cell Therapy Processing Systems Market is the high cost associated with the implementation and maintenance of advanced system technologies. These systems require significant investments in specialized equipment, training, and ongoing support, which can be a barrier for smaller healthcare facilities and research laboratories. Additionally, regulatory hurdles and concerns related to the standardization of automated processes can further complicate adoption, limiting market growth. As organizations weigh the benefits against the financial implications, the complexity and cost of integration may hinder wider implementation, stifling innovation and accessibility in cell therapy advancements.

Market Trends of the Global Automated And Closed Cell Therapy Processing Systems Market

The Global Automated and Closed Cell Therapy Processing Systems market is witnessing a significant trend towards standardization, which is enhancing scalability and operational efficiency. Industry-wide agreements on protocols, interfaces, and quality metrics are minimizing workflow inconsistencies and promoting modular interoperability across various platforms. This alignment among vendors and clinical experts on common data formats and validation frameworks is streamlining technology transfer processes, thereby fostering an ecosystem of reliable suppliers. As a result, operational friction is reduced, and regulatory discussions can concentrate on achieving consistent outcomes, enabling providers to confidently scale capacity and replicate successful therapies predictably and efficiently.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Automated And Closed Cell Therapy Processing Systems Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Cell Isolation Systems
• Cell Expansion Systems
• Cell Washing & Formulation
• Cryopreservation Systems

Global Automated And Closed Cell Therapy Processing Systems Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Automated Platforms
• Closed-Loop Systems

Global Automated And Closed Cell Therapy Processing Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• CAR-T Cell Manufacturing
• NK Cell Therapy
• Stem Cell Therapy

Global Automated And Closed Cell Therapy Processing Systems Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Cell Therapy Manufacturers
• Academic Research Centers
• CDMOs

Global Automated And Closed Cell Therapy Processing Systems Market Size & CAGR (2026-2033)

• North America (System Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (System Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System Type, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Miltenyi Biotec (CliniMACS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher) - Sepax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSpherix Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilson Wolf Manufacturing
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ori Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octane Biotech (Cytiva)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Multiply Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxCyte Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Cocoon Platform)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoGenesis Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Blood Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellero (Novatek)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCT (Hitachi)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAtla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellipont Bioservices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMPIO Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations